UBA1 is a known orchestrator of DNA damage response [79, 80], and coinciding with the discovery of VEXAS syndrome, UBA1 mutations were implicated as potential key factors in the development of lung cancer among non-smokers, identified through advanced bioinformatics methods [81]. This evidence concerns the gene UBA1 and lung cancer.